Global Manufacturing Partnerships Molteni operates a modern integrated development and manufacturing hub and has built strategic global partnerships, including manufacturing responsibilities for OncoZenge's BupiZenge and collaborations with Tilray to scale cannabis-based therapies in Europe, positioning Molteni as a preferred CDMO for complex regulated products.

Cannabis Therapeutics Growth Active engagement in cannabis-derived therapies via Tilray and regulatory/distribution initiatives with FL Group signals sales opportunities in Italy for cannabis extracts, education programs, and expanded patient access through EU-GMP certified platforms.

European Market Access Recent high-profile partnerships with Tilray and OncoZenge indicate Molteni as a bridge to European markets, offering distributors and hospital networks in Italy and beyond access to newly developed therapies and co-branded sales channels.

Pain and SUD Leadership Strength in pain management and substance use disorder therapies, including historical exclusive distribution for buprenorphine implants, creates cross-sell potential to healthcare systems and opportunities to co-develop new high-value formulations with partner firms.

EU CDMO Ready Mid-sized Italian pharma with EU-GMP manufacturing and strong compliance provides a compelling opportunity for SMEs seeking contract development and manufacturing services in Europe, leveraging Made in Italy heritage and a robust, safety-focused supply platform.